Rznomics, Inc. announced to secure its expanded access program (EAP) from the United States Food and Drug Administration (FDA) for RZ-001, RNA editing gene therapy product for the ...
It has been shown that silymarin is as active as quercetin and dihydroquercetin, and more active than quercitrin, in terms of antiperoxidant activity, independent of the experimental model used to ...
Significantly lower expression of UGT1A9 and UGT2B4 mRNA was identified in paediatric liver. Hepatic glucuronidation activity in children aged 13–24 months was found to be lower than in adults for ...